Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
JI

John A. Lowe, III — 85 Patents

Pfizer: 48 patents #15 of 5,153Top 1%
APAptinyx: 13 patents #2 of 2Top 100%
ALAlkermes: 7 patents #6 of 95Top 7%
RTRodin Therapeutics: 5 patents #1 of 9Top 15%
ALAlkermes Pharma Ireland Limited: 3 patents #47 of 116Top 45%
AGAgenebio: 2 patents #5 of 14Top 40%
LCLevel 3 Communications: 2 patents #598 of 1,318Top 50%
CTCadent Therapeutics: 1 patents #15 of 23Top 70%
Stonington, CT: #1 of 119 inventorsTop 1%
Connecticut: #156 of 34,797 inventorsTop 1%
Overall (All Time): #20,018 of 4,157,543Top 1%
85 Patents All Time
John A. Lowe, III has been granted 85 US patents while listed as an inventor at Pfizer. The first was granted in 1988 and the most recent in December 2024. John A. Lowe, III ranks #20,018 of 4,157,543 US inventors in our database (top 0.48%). Patent records list John A. Lowe, III in Stonington, CT, US.

Issued Patents All Time

Showing 1–25 of 85 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12167998 Spiro-lactam NMDA receptor modulators and uses thereof M. Amin Khan 2024-12-17
11987580 Bicyclic inhibitors of histone deacetylase Nathan Oliver Fuller 2024-05-21 $34,953,000
11912702 Substituted pyridines as inhibitors of histone deacetylase Nathan Oliver Fuller 2024-02-27 $42,431,000
11858939 Hetero-halo inhibitors of histone deacetylase Martin R. Jefson, Fabian Dey, Andreas Bergmann, Andreas Schoop, Nathan Oliver Fuller 2024-01-02 $40,202,000
11286256 Bicyclic inhibitors of histone deacetylase Nathan Oliver Fuller 2022-03-29 $37,889,000
11225490 Prodrugs of secondary amine compounds Laura Cook Blumberg, Orn Almarsson, Juan Alvarez, Tarek A. Zeidan 2022-01-18
11225479 Bicyclic inhibitors of histone deacetylase Nathan Oliver Fuller 2022-01-18 $18,298,000
11225475 Substituted pyridines as inhibitors of histone deacetylase Nathan Oliver Fuller 2022-01-18 $18,298,000
11077094 Spiro-lactam NMDA receptor modulators and uses thereof M. Amin Khan 2021-08-03 $2,670,000
10954250 Prodrugs of secondary amine compounds Laura Cook Blumberg, Orn Almarsson, Juan Alvarez, Tarek A. Zeidan 2021-03-23
10919902 Hetero-halo inhibitors of histone deacetylase Martin R. Jefson, Fabian Dey, Andreas Bergmann, Andreas Schoop, Nathan Oliver Fuller 2021-02-16 $34,616,000
10793567 Bicyclic inhibitors of histone deacetylase Nathan Oliver Fuller 2020-10-06
10774064 Potassium channel modulators Birgitte L. Eriksen, Magnus Gustafsson, Charlotte Hougaard, Thomas Amos Jacobsen, Martin R. Jefson +6 more 2020-09-15
10696673 Bicyclic inhibitors of histone deacetylase Nathan Oliver Fuller 2020-06-30
10519149 Bicyclic inhibitors of histone deacetylase Nathan Oliver Fuller 2019-12-31
10441571 Spiro-lactam NMDA receptor modulators and uses thereof M. Amin Khan 2019-10-15 $1,144,000
10441572 Spiro-lactam NMDA receptor modulators and uses thereof M. Amin Khan 2019-10-15 $1,144,000
10421756 Heterobicyclic N-aminophenyl-amides as inhibitors of histone deacetylase Martin R. Jefson, Fabian Dey, Andreas Bergmann, Andreas Schoop 2019-09-24
10316041 Spiro-lactam NMDA receptor modulators and uses thereof M. Amin Khan 2019-06-11 $2,454,000
10273239 Spiro-lactam NMDA receptor modulators and uses thereof M. Amin Khan 2019-04-30 $2,970,000
10253032 Spiro-lactam NMDA receptor modulators and uses thereof M. Amin Khan 2019-04-09 $3,153,000
10052308 Spiro-lactam NMDA receptor modulators and uses thereof M. Amin Khan 2018-08-21 $9,948,000
9951069 Bicyclic inhibitors of histone deacetylase Nathan Oliver Fuller 2018-04-24
9828384 Spiro-lactam NMDA receptor modulators and uses thereof M. Amin Khan 2017-11-28
9801879 Pyridazine derivatives, compositions and methods for treating cognitive impairment 2017-10-31